CRISPR Therapeutics to Present at the 2022 Bank of America Healthcare Conference

ZUG, Switzerland and CAMBRIDGE, Mass. , May 04, 2022 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team are scheduled to